Replies to post #113258 on Biotech Values

[DewDiligence]

Your thesis vis-à-vis Amphastar’s suit against the FDA has some merit, but I find it less plausible than the scenario outlined in #msg-59172130.

I would be willing to bet that, behind closed doors, FDA staffers describe Amphastar’s lawsuit as a complete joke. I would also be willing to bet that, behind closed doors, Teva’s executives are seriously worried about the corporate harm that might ensue from legal discovery in NVS/MNTA’s patent-infringement suit.

[DragonBits]

A minor minor deficiency requires the FDA to respond in 60 days.

When MNTA got the aprovable letter in 2007, how fast did MNTA respond and how long did it take the FDA to respond in turn?